3,167
Views
34
CrossRef citations to date
0
Altmetric
Research Paper

ADAR1 deletion induces NFκB and interferon signaling dependent liver inflammation and fibrosis

, , , , , , , , , , , , & show all
Pages 587-602 | Received 03 Mar 2016, Accepted 14 Jun 2016, Published online: 28 Jul 2016

References

  • Li S, Mason CE. The pivotal regulatory landscape of RNA modifications. Ann Rev Genomics Hum Genet 2014; 15:127-50; PMID:24898039; http://dx.doi.org/10.1146/annurev-genom-090413-025405
  • Bazak L, Haviv A, Barak M, Jacob-Hirsch J, Deng P, Zhang R, Isaacs FJ, Rechavi G, Li JB, Eisenberg E, et al. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res 2014; 24:365-76; PMID:24347612; http://dx.doi.org/10.1101/gr.164749.113
  • Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K, Jacob-Hirsch J, Amariglio N, Kupiec M, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 2012; 485:201-6; PMID:22575960; http://dx.doi.org/10.1038/nature11112
  • Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D, et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol 2004; 22:1001-5; PMID:15258596; http://dx.doi.org/10.1038/nbt996
  • Patterson JB, Samuel CE. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol 1995; 15:5376-88; PMID:7565688; http://dx.doi.org/10.1128/MCB.15.10.5376
  • Mannion N, Arieti F, Gallo A, Keegan LP, O'Connell MA. New insights into the biological role of mammalian ADARs; the RNA editing proteins. Biomolecules 2015; 5:2338-62; PMID:26437436; http://dx.doi.org/10.3390/biom5042338
  • Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 2009; 79:321-49; PMID:NOT_FOUND; http://dx.doi.org/10.1146/annurev-biochem-060208-105251
  • Amariglio N, Rechavi G. A-to-I RNA editing: a new regulatory mechanism of global gene expression. Blood Cells Mol Dis 2007; 39:151-5; PMID:17555993; http://dx.doi.org/10.1016/j.bcmd.2007.04.003
  • Barak M, Levanon EY, Eisenberg E, Paz N, Rechavi G, Church GM, Mehr R. Evidence for large diversity in the human transcriptome created by Alu RNA editing. Nucleic Acids Res 2009; 37:6905-15; PMID:19740767; http://dx.doi.org/10.1093/nar/gkp729
  • Eisenberg E, Adamsky K, Cohen L, Amariglio N, Hirshberg A, Rechavi G, Levanon EY. Identification of RNA editing sites in the SNP database. Nucleic Acids Res 2005; 33:4612-7; PMID:16100382; http://dx.doi.org/10.1093/nar/gki771
  • Neeman Y, Levanon EY, Jantsch MF, Eisenberg E. RNA editing level in the mouse is determined by the genomic repeat repertoire. RNA 2006; 12:1802-9; PMID:16940548; http://dx.doi.org/10.1261/rna.165106
  • Hartner JC, Walkley CR, Lu J, Orkin SH. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol 2009; 10:109-15; PMID:19060901; http://dx.doi.org/10.1038/ni.1680
  • Mannion NM, Greenwood SM, Young R, Cox S, Brindle J, Read D, Nellaker C, Vesely C, Ponting CP, McLaughlin PJ, et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep 2014; 9:1482-94; PMID:25456137; http://dx.doi.org/10.1016/j.celrep.2014.10.041
  • Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, Szynkiewicz M, Dickerson JE, Bhaskar SS, Zampini M, Briggs TA, et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genet 2012; 44:1243-8; PMID:23001123; http://dx.doi.org/10.1038/ng.2414
  • Rice G, Patrick T, Parmar R, Taylor CF, Aeby A, Aicardi J, Artuch R, Montalto SA, Bacino CA, Barroso B, et al. Clinical and molecular phenotype of aicardi-goutières syndrome. Am J Hum Genet 2007; 81:713-25; PMID:17846997; http://dx.doi.org/10.1086/521373
  • O'Connell MA, Mannion NM, Keegan LP. The epitranscriptome and innate immunity. PLoS Genet 2015; 11:e1005687; PMID:26658668; http://dx.doi.org/10.1371/journal.pgen.1005687
  • Ota H, Sakurai M, Gupta R, Valente L, Wulff BE, Ariyoshi K, Iizasa H, Davuluri RV, Nishikura K. ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell 2013; 153:575-89; PMID:23622242; http://dx.doi.org/10.1016/j.cell.2013.03.024
  • Pestal K, Funk CC, Snyder JM, Price ND, Treuting PM, Stetson DB. Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development. Immunity 2015; 43:933-44; PMID:26588779; http://dx.doi.org/10.1016/j.immuni.2015.11.001
  • Friedman SL. Mechanisms of Hepatic Fibrogenesis. Gastroenterology 2008; 134:1655-69; PMID:18471545; http://dx.doi.org/10.1053/j.gastro.2008.03.003
  • Friedman SL. Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury. J Biol Chem 2000; 275:2247-50; PMID:10644669; http://dx.doi.org/10.1074/jbc.275.4.2247
  • Friedman SL. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88:125-72; PMID:18195085; http://dx.doi.org/10.1152/physrev.00013.2007
  • Benyon RC, Arthur MJP. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001; 21:373-84; PMID:11586466; http://dx.doi.org/10.1055/s-2001-17552
  • Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 2011; 12:715-23; PMID:21772280; http://dx.doi.org/10.1038/ni.2060
  • Hartner JC, Schmittwolf C, Kispert A, Müller AM, Higuchi M, Seeburg PH. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 2004; 279:4894-902; PMID:14615479; http://dx.doi.org/10.1074/jbc.M311347200
  • Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999; 274:305-15; PMID:9867845; http://dx.doi.org/10.1074/jbc.274.1.305
  • Zambelli F, Pesole G, Pavesi G. Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes. Nucleic Acids Res 2009; 37:W247-W52; PMID:19487240; http://dx.doi.org/10.1093/nar/gkp464
  • Choi I, Kang HS, Yang Y, Pyun KH. IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clin Exp Immunol 1994; 95:530-5; PMID:8137551; http://dx.doi.org/10.1111/j.1365-2249.1994.tb07031.x
  • Nemlich Y, Greenberg E, Ortenberg R, Besser MJ, Barshack I, Jacob-Hirsch J, Jacoby E, Eyal E, Rivkin L, Prieto VG, et al. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Invest 2013; 123:2703-18; PMID:23728176; http://dx.doi.org/10.1172/JCI62980
  • Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25:280-8; PMID:15145317; http://dx.doi.org/10.1016/j.it.2004.03.008
  • Nieto N. Oxidative-stress and IL-6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells. Hepatology 2006; 44:1487-501; PMID:17133487; http://dx.doi.org/10.1002/hep.21427
  • Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, Chisari FV. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77:68-76; PMID:12477811; http://dx.doi.org/10.1128/JVI.77.1.68-76.2003
  • Ichiki Y, Aoki CA, Bowlus CL, Shimoda S, Ishibashi H, Gershwin ME. T cell immunity in autoimmune hepatitis. Autoimmu Rev 2005; 4:315-21; PMID:15990080; http://dx.doi.org/10.1016/j.autrev.2005.01.005
  • Liddicoat BJ, Piskol R, Chalk AM, Ramaswami G, Higuchi M, Hartner JC, Li JB, Seeburg PH, Walkley CR. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 2015; 349:1115-20; PMID:26275108; http://dx.doi.org/10.1126/science.aac7049
  • Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000; 18:621-63; PMID:10837071; http://dx.doi.org/10.1146/annurev.immunol.18.1.621
  • Wang G, Wang H, Singh S, Zhou P, Yang S, Wang Y, Zhu Z, Zhang J, Chen A, Billiar T, et al. ADAR1 prevents liver injury from inflammation and suppresses interferon production in hepatocytes. Am J Pathol 2015; 185:3224-37; PMID:26453800; http://dx.doi.org/10.1016/j.ajpath.2015.08.002
  • Zigmond E, Samia-Grinberg S, Pasmanik-Chor M, Brazowski E, Shibolet O, Halpern Z, Varol C. Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury. J Immunol 2014; 193:344-53; PMID:24890723; http://dx.doi.org/10.4049/jimmunol.1400574
  • DiDonato JA, Mercurio F, Karin M. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol Cell Biol 1995; 15:1302-11; PMID:7862124; http://dx.doi.org/10.1128/MCB.15.3.1302

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.